These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14682007)

  • 21. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ultrasonographical predictive factors of ovarian response to stimulation prior to in vitro fertilization].
    Ebrard-Charra S; Reyftmann L; Hédon B; Déchaud H
    Gynecol Obstet Fertil; 2005 Oct; 33(10):762-7. PubMed ID: 16154374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome.
    Fábregues F; Balasch J; Creus M; Carmona F; Puerto B; Quintó L; Casamitjana R; Vanrell JA
    J Assist Reprod Genet; 2000 Jan; 17(1):13-9. PubMed ID: 10754778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women.
    De Pergola G; Maldera S; Tartagni M; Pannacciulli N; Loverro G; Giorgino R
    Obesity (Silver Spring); 2006 Nov; 14(11):1954-60. PubMed ID: 17135611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls.
    de Koning CH; McDonnell J; Themmen AP; de Jong FH; Homburg R; Lambalk CB
    Hum Reprod; 2008 Jun; 23(6):1416-23. PubMed ID: 18375407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can quantitative three-dimensional power Doppler angiography be used to predict ovarian hyperstimulation syndrome?
    Jayaprakasan K; Jayaprakasan R; Al-Hasie HA; Clewes JS; Campbell BK; Johnson IR; Raine-Fenning NJ
    Ultrasound Obstet Gynecol; 2009 May; 33(5):583-91. PubMed ID: 19402100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of inhibin B as a basal determinant of ovarian reserve.
    Fiçicioğlu C; Kutlu T; Demirbaşoğlu S; Mulayim B
    Gynecol Endocrinol; 2003 Aug; 17(4):287-93. PubMed ID: 14503972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
    McIlveen M; Skull JD; Ledger WL
    Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level.
    Hendriks DJ; Mol BW; Bancsi LF; Te Velde ER; Broekmans FJ
    Fertil Steril; 2005 Feb; 83(2):291-301. PubMed ID: 15705365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early follicle development during the luteal-follicular transition affects the predictability of serum follicle-stimulating hormone but not antimüllerian hormone levels on cycle day 3.
    Grynberg M; Genro V; Gallot V; El-Ali A; Frydman R; Fanchin R
    Fertil Steril; 2010 Oct; 94(5):1827-31. PubMed ID: 19878941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DHEA supplementation may improve IVF outcome in poor responders: a proposed mechanism.
    Hyman JH; Margalioth EJ; Rabinowitz R; Tsafrir A; Gal M; Alerhand S; Algur N; Eldar-Geva T
    Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):49-53. PubMed ID: 23312476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases.
    van den Berg MH; van Dulmen-den Broeder E; Overbeek A; Twisk JW; Schats R; van Leeuwen FE; Kaspers GJ; Lambalk CB
    Hum Reprod; 2010 Jun; 25(6):1520-7. PubMed ID: 20348556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective analysis of ovarian reserve markers as determinant in response to controlled ovarian stimulation in women undergoing IVF cycles in low resource setting in India.
    Singh N; Bahadur A; Malhotra N; Kalaivani M; Mittal S
    Arch Gynecol Obstet; 2013 Sep; 288(3):697-703. PubMed ID: 23529683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of number and diameter of follicles on plasma concentrations of inhibin and FSH in mares.
    Donadeu FX; Ginther OJ
    Reproduction; 2001 Jun; 121(6):897-903. PubMed ID: 11373176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does obesity compromise ovarian reserve markers? A clinician's perspective.
    Malhotra N; Bahadur A; Singh N; Kalaivani M; Mittal S
    Arch Gynecol Obstet; 2013 Jan; 287(1):161-6. PubMed ID: 22930149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women.
    Reame NE; Wyman TL; Phillips DJ; de Kretser DM; Padmanabhan V
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3302-7. PubMed ID: 9745445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S; Suharjono H; McGarrigle H; Sathanandan M
    BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
    Schipper I; Hop WC; Fauser BC
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.